Jubilant Biosys, an international contract research organisation (CRO), has provided drug discovery and contract research services to the global pharmaceutical industry for 20 years.
“Our vision is to become a top 10 CRO/CDMO and deliver ‘the added dimension’ in discovery services,” said Marcel Velterop, President Drug Discovery Services and CDMO at Jubilant Biosys.
“We symbolise this by our 4D brand, which promises to accelerate all aspects of both functional and integrated services to our innovative customers around the world. Introducing a digital agenda is a key part of this promise, and a range of initiatives have started, including CDD Vault ELN implementation.”
Read the full article to learn how Jubilant Biosys realized a full suite of benefits by digitalizing data capture, management, and sharing.
Meer zien